Epidermal Growth Factor Receptor Mutation Status and Rad51 Determine the Response of Glioblastoma to Multimodality Therapy with Cetuximab, Temozolomide, and Radiation
Phyllis Wachsberger(Thomas Jefferson University), Adam P. Dicker(Thomas Jefferson University Hospital)
Cited by 15
Related Papers
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
|Journal of Clinical Oncology|2015|903
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
|Journal of Clinical Oncology|2016|654
Betulinic acid sensitization of low pH adapted human melanoma cells to hyperthermia
|International Journal of Hyperthermia|2002|29
Abstract 2452: Proteomic aging biomarkers predict survival in immunotherapy-treated tumors
|Cancer Research|2026|0